ArticleOncology letters2021

Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma.

Yasutaka Itashiki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.